Cargando…
Type 2 diabetes drug glitazone may help lowering risk of dementia by 22%
Autores principales: | Fareed, Areeba, Rohail, Samia, Kamran, Ateeba |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129125/ https://www.ncbi.nlm.nih.gov/pubmed/37113972 http://dx.doi.org/10.1097/MS9.0000000000000221 |
Ejemplares similares
-
Detection of vaccine-derived poliovirus type 2 amid the burden of infectious diseases in the UK: A cause for alarm
por: Kamran, Ateeba, et al.
Publicado: (2022) -
DCvax: A promising advancement in oncology for the treatment of glioblastoma
por: Fareed, Areeba, et al.
Publicado: (2023) -
Nirogacestat and its potential impact on desmoid tumor
por: Rohail, Samia, et al.
Publicado: (2023) -
Are the adverse effects of glitazones linked to induced testosterone deficiency?
por: Carruthers, M, et al.
Publicado: (2008) -
Pleiotropic Effects of Glitazones: A Double Edge Sword?
por: Salomone, Salvatore
Publicado: (2011)